These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis. Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598 [TBL] [Abstract][Full Text] [Related]
3. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968 [TBL] [Abstract][Full Text] [Related]
4. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696 [TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741 [TBL] [Abstract][Full Text] [Related]
6. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562 [TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Schmidt H; Dalhoff A; Stuertz K; Trostdorf F; Chen V; Schneider O; Kohlsdorfer C; Brück W; Nau R Antimicrob Agents Chemother; 1998 Jun; 42(6):1397-407. PubMed ID: 9624483 [TBL] [Abstract][Full Text] [Related]
10. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis. Tarasi A; Dever LL; Tomasz A J Antimicrob Chemother; 1997 May; 39 Suppl A():121-7. PubMed ID: 9511076 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. McCracken GH; Sakata Y Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. Täuber MG; Doroshow CA; Hackbarth CJ; Rusnak MG; Drake TA; Sande MA J Infect Dis; 1984 Apr; 149(4):568-74. PubMed ID: 6327835 [TBL] [Abstract][Full Text] [Related]
15. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131 [TBL] [Abstract][Full Text] [Related]
16. High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Ostergaard C; Sandvang D; Frimodt-Møller N; Kristensen HH Antimicrob Agents Chemother; 2009 Apr; 53(4):1581-5. PubMed ID: 19188395 [TBL] [Abstract][Full Text] [Related]
17. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel. Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882 [TBL] [Abstract][Full Text] [Related]